Catalyst Event

Jiangsu Hengrui Pharmaceuticals Co Ltd (1276) · Earnings Release

From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)

3/25/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Announced 2025 annual results with revenue up 13.02% YoY to RMB 31.63 billion and net profit up 21.69% YoY to RMB 7.71 billion. A final dividend of RMB 2.00 per 10 shares was proposed. Medium impact estimated due to significant profit growth scheduled

Korean Translation

2025년 연간 실적 발표, 매출은 전년 대비 13.02% 증가한 316.3억 위안, 순이익은 21.69% 증가한 77.1억 위안을 기록함. 10주당 2.00위안의 결산 배당을 제안함. 상당한 이익 성장으로 중간 수준의 영향이 예상됨

Related Recent Events

View Full Timeline